Brazil's largest medical diagnostics network has spent six decades stitching together hospitals, labs, and cancer clinics from São Paulo to Buenos Aires — yet the bill for all that stitching is still coming due, and the company has not turned a net profit in years. Full nameDiagnósticos da América S.A. (Dasa) Ticker / exchangeDASA3 — B3 (São Paulo) HeadquartersBarueri, Greater São Paulo, Brazil SectorHealthcare — Diagnostics & Research Employees26,255 Market value (market cap)R$3.14bn (US$610 mn) (~$609m) Yearly sales (revenue, FY2024)R$15.32bn (US$3.0 bn) (~$2.97bn) Net profit (FY2024)–R$1.20bn (US$233 mn) (–$233m loss) …
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →